Tag: positron emission tomography pet radiotracer market analysis

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Market Size Of The Positron Emission Tomography (PET) Radiotracer Market Expected To Scale Between 2026 And 2030?

The positron emission tomography (pet) radiotracer market size has seen significant growth in recent years. It is anticipated to increase from $2.54 billion in 2025 to $2.78 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.2%. This historical expansion can be linked to several factors, including a rise in cancer diagnosis rates, the expansion of nuclear medicine facilities, the well-established utilization of FDG-based imaging, the presence of cyclotron infrastructure, and the overall growth in diagnostic imaging services.

The positron emission tomography (pet) radiotracer market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $3.95 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. Key drivers of this growth during the forecast period include an escalating demand for precise diagnostic tools, increased capital allocation towards radiopharmaceutical research and development, the broadening scope of theranostics applications, greater integration of PET imaging in neurological and cardiovascular diagnostics, and a rise in regulatory clearances for novel tracers. Significant trends expected over the forecast horizon encompass the accelerated creation of target-specific radiotracers, a surge in PET imaging utilization for oncology diagnostics, the expanding application of new isotopes beyond FDG, the proliferation of personalized nuclear medicine applications, and a heightened emphasis on producing radiotracers with short half-lives.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

What Key Factors Are Shaping The Positron Emission Tomography (PET) Radiotracer Market Landscape?

A rise in infectious disease cases is anticipated to drive the expansion of the positron emission tomography (PET) radiotracer market in the coming period. These diseases are defined as conditions resulting from pathogenic microorganisms like bacteria, viruses, fungi, or parasites. Factors contributing to the increasing incidence of infectious diseases include climate change, urbanization, globalization, antibiotic resistance, and shifts in human behavior, all of which aid pathogen dissemination. Positron emission tomography (PET) radiotracers assist in managing infectious diseases through their ability to visualize metabolic activity and inflammation, thereby facilitating infection detection, evaluating treatment efficacy, and distinguishing between infectious and non-infectious states, ultimately leading to improved patient results. As an illustration, a report released by the UK Health Security Agency, a UK-based government body, indicated in February 2024 that tuberculosis (TB) cases in England saw a 10.7% rise in 2023, reaching 4,850 cases from 4,380 reported in 2022. Consequently, the growing occurrence of infectious diseases is fueling the expansion of the positron emission tomography (PET) radiotracer market.

Which Segment Types Are Examined In The Positron Emission Tomography (PET) Radiotracer Market Segment Study?

The positron emission tomography (pet) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

What Market Trends Are Affecting The Positron Emission Tomography (PET) Radiotracer Market?

Leading firms within the positron emission tomography (PET) radiotracer market are concentrating their efforts on creating sophisticated diagnostic options, including positron emission tomography imaging agents, with the goal of improving cancer identification and enhancing patient results. A PET imaging agent is defined as a radioactive compound utilized for visualizing and quantifying biological activities within the body during PET scans. As an illustration, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canadian radiopharmaceutical firm, introduced Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in Canada. This product serves as a prostate cancer imaging agent specifically developed for detecting metastatic prostate cancer. This particular diagnostic instrument proves beneficial for clinicians in pinpointing metastatic disease and assisting with patient management choices. Its application is recommended for patients with suspected metastasis who are eligible for initial definitive treatment, and also for individuals with suspected recurrence, evidenced by elevated serum prostate-specific antigen (PSA) levels.

Which Players Are Part Of The Competitive Landscape Of The Positron Emission Tomography (PET) Radiotracer Market?

Major companies operating in the positron emission tomography (pet) radiotracer market are Cardinal Health Inc., GE Healthcare Technologies Inc., Bracco Imaging S.p.A., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences, Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., ImaginAb Inc., Radiomedix Inc., Curium Pharma, Blue Earth Diagnostics Ltd., Eckert & Ziegler Radiopharma GmbH, Advanced Accelerator Applications (Novartis), Telix Pharmaceuticals Limited, PETNET Solutions Inc., Piramal Imaging

Get The Full Positron Emission Tomography (PET) Radiotracer Market Report:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which Region Dominates The Positron Emission Tomography (PET) Radiotracer Market By Market Share?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (pet) radiotracer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Positron Emission Tomography (PET) Radiotracer Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Browse Through More Reports Similar to the Global Positron Emission Tomography (PET) Radiotracer Market 2026, By The Business Research Company

Poc Medical Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/poc-medical-imaging-global-market-report

Veterinary Imaging Market Report 2026

https://www.thebusinessresearchcompany.com/report/veterinary-imaging-global-market-report

Pet Tech Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-tech-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Key Milestones in the Positron Emission Tomography (PET) Radiotracer Market’s Growth Trajectory From 2025 To 2034?

The market size for the positron emission tomography (pet) radiotracer has seen robust growth in recent times. The forecasts suggest a growth from $2.35 billion in 2024, skyrocketing to $2.54 billion in 2025 with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to this surge in the historical period include a rise in infectious diseases, expanded awareness and accessibility, the evolution of new radiotracers, an escalation in cancer prevalence, and an increased emphasis on preventive healthcare.

In the coming years, a robust growth is anticipated for the positron emission tomography (pet) radiotracer market, as it’s projected to expand to $3.61 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.2%. The growth during the forecast period is set to be driven by factors such as increased application range, regulatory approval, advancement in emerging markets, the rise of the elderly population, and increasing usage of PET radio scanners. The forecast period is also likely to witness several trends including the evolution of micro-pet technology, integration of wearable technology, the rise of theranostics, development of nano-radiotracers, and the application of blockchain for data security.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Positron Emission Tomography (PET) Radiotracer Market?

Anticipated growth in the positron emission tomography (PET) radiotracer market is being driven by a rise in the prevalence of infectious diseases. These illnesses, identifiable as ones caused by bacteria, viruses, fungi, or parasites, are being further propagated by factors such as climate change, urbanisation, globalisation, antibiotic resistance, and shifts in human behaviours. Using PET radiotracers, healthcare professionals can visualise metabolic activity and inflammation, making it possible to identify infections, gauge treatment efficacy and distinguish between infectious and non-infectious conditions. This aids in securing better results for patients. For instance, the UK Health Security Agency reported an increase of 10.7% in tuberculosis (TB) cases in England in February 2024, with a rise to 4,850 from 4,380 cases in the previous year. The escalating prevalence of infectious diseases is thus expected to drive the growth of the PET radiotracer market.

Which Primary Segments of the Positron Emission Tomography (PET) Radiotracer Market Are Driving Growth and Industry Transformations?

The positron emission tomography (pet) radiotracermarket covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=19152&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Positron Emission Tomography (PET) Radiotracer Market?# Market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Positron Emission Tomography (PET) Radiotracer Market?

Established corporations in the positron emission tomography (PET) radiotracer industry are concentrating on the invention of cutting-edge diagnostic tools, like positron emission tomography imaging agents, with an emphasis on increasing cancer detection rates and bettering patient results. A PET imaging agent is essentially a radioactive material used to monitor and analyze biological functions in the body during PET scans. For instance, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm located in Canada, introduced Illuccix, also recognized as Ga-68 Gozetotide Preparation Kit (PSMA-11), designed to detect metastatic prostate cancer in Canada in March 2023. This instrument is a crucial resource for medical practitioners to detect metastatic diseases and support in patient management choices. It is recommended for use in patients who are suspected of metastasis and are set for initial definitive therapy, as well as in individuals showing suspected recurrence as indicated by elevated serum prostate-specific antigen (PSA) levels.

View the full report here:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

What Parameters Are Used to Define the Positron Emission Tomography (PET) Radiotracer Market?

A positron emission tomography (PET) radiotracer refers to a radioactive substance used in positron emission tomography (PET) imaging. A PET radiotracer is utilized by injecting a patient with a radioactive substance that binds to specific biological targets, allowing the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the positron emission tomography (pet) radiotracer industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Are the Key Milestones in the Positron Emission Tomography (PET) Radiotracer Market’s Growth Trajectory From 2025 To 2034?#_x000D_

In recent times, the market for positron emission tomography (PET) radiotracer has experienced significant growth. The market, valued at $2.35 billion in 2024, is projected to reach $2.57 billion in 2025, escalating at a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the historical period include an increased prevalence of infectious diseases, increased awareness and accessibility, development of new radiotracers, a higher incidence of cancer, and an intensified focus on preventive healthcare._x000D_

_x000D_

In the coming years, the market size for radiotracers used in positron emission tomography (PET) is anticipated to experience significant growth, reaching a value of $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 9.1%. This projected growth within the forecast period can be attributed to an assortment of factors including the widening of applications, regulatory approvals, market growth in emerging regions, an increasing older population, and a rising frequency of PET radio scanner use. Key trends anticipated within the forecast period include the advent of micro-pet technology, integration with wearable tech, growth in the area of theranostics, the development of nano-radiotracers, and the use of blockchain for enhancing data security._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp_x000D_

_x000D_

#What are the Fundamental Drivers and Innovations Shaping the Positron Emission Tomography (PET) Radiotracer Market?#_x000D_

The growth of the positron emission tomography (PET) radiotracer market is set to be fueled by the escalating prevalence of infectious diseases. Such diseases arise from pathogenic microorganisms like bacteria, fungi, parasites, or viruses. The upsurge in these diseases is attributed to factors such as climate change, urbanization, globalization, antibiotic resilience, and alterations in human behaviors which hasten the distribution of pathogens. PET radiotracers play a vital role in managing infectious diseases by providing visualization of metabolic activity and inflammation. This assists in the detection of infection, evaluating the efficacy of treatment, and distinguishing between infectious and non-infectious conditions for improved patient prognosis. For example, as per a report disseminated by the UK Health Security Agency in February 2024, there was a rise of 10.7% in tuberculosis (TB) cases in England in 2023, reporting 4,850 cases, up from 4,380 in 2022. Consequently, the burgeoning incidence of infectious diseases is propelling the PET radiotracer market growth._x000D_

_x000D_

#How Is the Positron Emission Tomography (PET) Radiotracer Market Segmented?#_x000D_

The positron emission tomography (PET) radiotracer market covered in this report is segmented –_x000D_

_x000D_

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types_x000D_

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications_x000D_

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)_x000D_

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)_x000D_

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=19152&type=smp_x000D_

_x000D_

#Which Regions Are Driving the Next Phase of the Positron Emission Tomography (PET) Radiotracer Market Growth?#_x000D_

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Most Significant Market Trends in the Positron Emission Tomography (PET) Radiotracer Market?#_x000D_

Leading firms in the positron emission tomography (PET) radiotracer market are concentrating on the development of superior diagnostic tools such as PET imaging agents, with the goal of amplifying cancer detection and enriching patient prognosis. A PET imaging agent is a radioactive substance employed to image and quantify biological processes in the body during PET scans. For example, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical corporation based in Canada, unveiled Illuccix, also known as the Ga-68 Gozetotide Preparation Kit (PSMA-11), in March 2023 to serve as a prostate cancer imaging agent designed to track metastatic prostate cancer. This resource is significant for doctors as it helps them identify metastatic illnesses and assist in patient care decisions. It is recommended for patients suspected of having metastases who are potential candidates for initial definitive treatment, and for those suspected of having a recurrence reflected by elevated serum prostate-specific antigen (PSA) levels._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report_x000D_

_x000D_

#How Is the Positron Emission Tomography (PET) Radiotracer Market Defined and What Are Its Core Parameters?#_x000D_

A positron emission tomography (PET) radiotracer refers to a radioactive substance used in positron emission tomography (PET) imaging. A PET radiotracer is utilized by injecting a patient with a radioactive substance that binds to specific biological targets, allowing the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

How Are Key Drivers Contributing to the Growth and Expansion of the Positron Emission Tomography (PET) Radiotracer Market?

The growing prevalence of infectious diseases is expected to drive the positron emission tomography (PET) radiotracer market. These diseases are on the rise due to factors like climate change, urbanization, and antibiotic resistance. PET radiotracers help detect infections, monitor treatment responses, and distinguish between infectious and non-infectious conditions. According to the UK Health Security Agency, tuberculosis cases in England increased by 10.7% in 2023. The rising prevalence of infectious diseases is propelling the growth of the PET radiotracer market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

#How Will the CAGR of the Positron Emission Tomography (PET) Radiotracer Market Influence Its Overall Growth by 2034?

The positron emission tomography (PET) radiotracer market size will grow from $2.35 billion in 2024 to $2.57 billion in 2025 at a CAGR of 9.3%. The growth is attributed to the prevalence of infectious diseases, awareness and accessibility, novel radiotracers, rising cancer rates, and focus on preventive medicine.

The positron emission tomography (PET) radiotracer market is expected to grow to $3.63 billion by 2029 at a CAGR of 9.1%. Growth is attributed to expanded applications, regulatory approvals, emerging markets, the aging population, and increased adoption of PET scanners. Major trends include micro-PET technology, wearable tech integration, theranostics, nano-radiotracers, and blockchain for data security.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

What New Market Trends Are Reshaping thePositron Emission Tomography (PET) Radiotracer Market and Its Opportunities?

Companies in the positron emission tomography (PET) radiotracer market are focusing on developing advanced diagnostic solutions, like PET imaging agents, to improve cancer detection and patient outcomes. PET imaging agents are radioactive substances used in PET scans to visualize and measure biological processes in the body. For instance, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a Canada-based radiopharmaceutical company, introduced Illuccix, a prostate cancer imaging agent designed to detect metastatic prostate cancer. This tool aids physicians in identifying metastatic disease and supporting patient management decisions.

Who Are the Leading Market Players Fueling Growth in the Positron Emission Tomography (PET) Radiotracer Market Trend?

Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

How is the Global Positron Emission Tomography (PET) Radiotracer Market Segemented?

The positron emission tomography (PET) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=19152&type=smp

Which Geographics are Influencing the Growth of the Positron Emission Tomography (PET) Radiotracer Market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Positron Emission Tomography (PET) Radiotracer Market 2025, By The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Cloud-Radio Access Network Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-radio-access-network-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the positron emission tomography (pet) radiotracer market grown in recent years?

The positron emission tomography (PET) radiotracer market has expanded significantly, projected to rise from $2.35 billion in 2024 to $2.57 billion in 2025 at a CAGR of 9.3%. Growth drivers include increasing infectious disease prevalence, greater awareness and accessibility, the emergence of novel radiotracers, rising cancer cases, and a stronger focus on preventive medicine.

How is the positron emission tomography (pet) radiotracer market size expected to evolve during the forecast period?

The positron emission tomography (PET) radiotracer market is projected to grow significantly, reaching $3.63 billion by 2029 at a CAGR of 9.1%, fueled by expanding applications, regulatory approvals, increasing presence in emerging markets, a growing elderly population, and wider adoption of PET radio scanners. Major trends include micro-PET technology, integration with wearable devices, expansion of theranostics, nano-radiotracers, and blockchain for data security.

Get your positron emission tomography (pet) radiotracer market report here!

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which key drivers are propelling the positron emission tomography (pet) radiotracer market’s growth?

The increasing prevalence of infectious diseases is expected to propel the growth of the positron emission tomography (PET) radiotracer market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. The rising prevalence of infectious diseases is due to climate change, urbanization, globalization, antibiotic resistance, and changes in human behavior, which all facilitate the spread of pathogens. Positron emission tomography (PET) radiotracers help infectious diseases by visualizing metabolic activity and inflammation, enabling detection of infection, assessment of treatment response, and differentiation between infectious and non-infectious conditions for better patient outcomes. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the positron emission tomography (PET) radiotracer market.

What are the market segments in the positron emission tomography (pet) radiotracer industry?

The positron emission tomography (PET) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

Which leading companies are shaping the growth of the positron emission tomography (pet) radiotracer market?

Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

What key trends are currently impacting the positron emission tomography (pet) radiotracer market’s development?

Leading businesses in the PET radiotracer market are prioritizing the creation of innovative diagnostic tools such as PET imaging agents to boost the detection of cancer and improve patient prognosis. PET imaging agents are radioactive substances used in PET scans to view and track bodily functions. For example, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm based in Canada, introduced Illuccix, alternatively known as the Ga-68 Gozetotide Preparation Kit (PSMA-11) in Canada, which is a prostate cancer imaging agent specifically created to detect metastatic prostate cancer. This equipment is beneficial to doctors for detecting metastatic illnesses and assisting in patient care decisions. It is intended for use in patients suspected of developing metastasis and are considered for initial definitive treatment and those suspected of recurrence as signaled by a rise in serum prostate-specific antigen (PSA) levels.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

Which geographic areas are influencing the growth of the positron emission tomography (pet) radiotracer market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Cloud-Radio Access Network Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-radio-access-network-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the positron emission tomography (pet) radiotracer market grown in recent years?

The positron emission tomography (PET) radiotracer market has expanded significantly, projected to rise from $2.35 billion in 2024 to $2.57 billion in 2025 at a CAGR of 9.3%. Growth drivers include increasing infectious disease prevalence, greater awareness and accessibility, the emergence of novel radiotracers, rising cancer cases, and a stronger focus on preventive medicine.

How is the positron emission tomography (pet) radiotracer market size expected to evolve during the forecast period?

The positron emission tomography (PET) radiotracer market is projected to grow significantly, reaching $3.63 billion by 2029 at a CAGR of 9.1%, fueled by expanding applications, regulatory approvals, increasing presence in emerging markets, a growing elderly population, and wider adoption of PET radio scanners. Major trends include micro-PET technology, integration with wearable devices, expansion of theranostics, nano-radiotracers, and blockchain for data security.

Get your positron emission tomography (pet) radiotracer market report here!

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which key drivers are propelling the positron emission tomography (pet) radiotracer market’s growth?

The increasing prevalence of infectious diseases is expected to propel the growth of the positron emission tomography (PET) radiotracer market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. The rising prevalence of infectious diseases is due to climate change, urbanization, globalization, antibiotic resistance, and changes in human behavior, which all facilitate the spread of pathogens. Positron emission tomography (PET) radiotracers help infectious diseases by visualizing metabolic activity and inflammation, enabling detection of infection, assessment of treatment response, and differentiation between infectious and non-infectious conditions for better patient outcomes. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the positron emission tomography (PET) radiotracer market.

What are the market segments in the positron emission tomography (pet) radiotracer industry?

The positron emission tomography (PET) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

Which leading companies are shaping the growth of the positron emission tomography (pet) radiotracer market?

Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

What key trends are currently impacting the positron emission tomography (pet) radiotracer market’s development?

Leading businesses in the PET radiotracer market are prioritizing the creation of innovative diagnostic tools such as PET imaging agents to boost the detection of cancer and improve patient prognosis. PET imaging agents are radioactive substances used in PET scans to view and track bodily functions. For example, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm based in Canada, introduced Illuccix, alternatively known as the Ga-68 Gozetotide Preparation Kit (PSMA-11) in Canada, which is a prostate cancer imaging agent specifically created to detect metastatic prostate cancer. This equipment is beneficial to doctors for detecting metastatic illnesses and assisting in patient care decisions. It is intended for use in patients suspected of developing metastasis and are considered for initial definitive treatment and those suspected of recurrence as signaled by a rise in serum prostate-specific antigen (PSA) levels.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

Which geographic areas are influencing the growth of the positron emission tomography (pet) radiotracer market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Cloud-Radio Access Network Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-radio-access-network-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the positron emission tomography (pet) radiotracer market grown in recent years?

The positron emission tomography (PET) radiotracer market has expanded significantly, projected to rise from $2.35 billion in 2024 to $2.57 billion in 2025 at a CAGR of 9.3%. Growth drivers include increasing infectious disease prevalence, greater awareness and accessibility, the emergence of novel radiotracers, rising cancer cases, and a stronger focus on preventive medicine.

How is the positron emission tomography (pet) radiotracer market size expected to evolve during the forecast period?

The positron emission tomography (PET) radiotracer market is projected to grow significantly, reaching $3.63 billion by 2029 at a CAGR of 9.1%, fueled by expanding applications, regulatory approvals, increasing presence in emerging markets, a growing elderly population, and wider adoption of PET radio scanners. Major trends include micro-PET technology, integration with wearable devices, expansion of theranostics, nano-radiotracers, and blockchain for data security.

Get your positron emission tomography (pet) radiotracer market report here!

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which key drivers are propelling the positron emission tomography (pet) radiotracer market’s growth?

The increasing prevalence of infectious diseases is expected to propel the growth of the positron emission tomography (PET) radiotracer market going forward. Infectious diseases refer to illnesses caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites. The rising prevalence of infectious diseases is due to climate change, urbanization, globalization, antibiotic resistance, and changes in human behavior, which all facilitate the spread of pathogens. Positron emission tomography (PET) radiotracers help infectious diseases by visualizing metabolic activity and inflammation, enabling detection of infection, assessment of treatment response, and differentiation between infectious and non-infectious conditions for better patient outcomes. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the positron emission tomography (PET) radiotracer market.

What are the market segments in the positron emission tomography (pet) radiotracer industry?

The positron emission tomography (PET) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

Which leading companies are shaping the growth of the positron emission tomography (pet) radiotracer market?

Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

What key trends are currently impacting the positron emission tomography (pet) radiotracer market’s development?

Leading businesses in the PET radiotracer market are prioritizing the creation of innovative diagnostic tools such as PET imaging agents to boost the detection of cancer and improve patient prognosis. PET imaging agents are radioactive substances used in PET scans to view and track bodily functions. For example, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm based in Canada, introduced Illuccix, alternatively known as the Ga-68 Gozetotide Preparation Kit (PSMA-11) in Canada, which is a prostate cancer imaging agent specifically created to detect metastatic prostate cancer. This equipment is beneficial to doctors for detecting metastatic illnesses and assisting in patient care decisions. It is intended for use in patients suspected of developing metastasis and are considered for initial definitive treatment and those suspected of recurrence as signaled by a rise in serum prostate-specific antigen (PSA) levels.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19152

Which geographic areas are influencing the growth of the positron emission tomography (pet) radiotracer market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Cloud-Radio Access Network Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-radio-access-network-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Positron Emission Tomography (PET) Radiotracer Market Shape Industry Trends by 2034?

In the past few years, the market size of the positron emission tomography (PET) radiotracer has seen significant growth. The market, which was valued at $2.35 billion in 2024, is projected to grow to $2.57 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. The historic increase in this market can be tied to several factors including escalated incidences of infectious diseases, heightened awareness and access, the development of new radiotracers, an increased number of cancer cases, and an intensified focus on preventive healthcare.

The market size for the positron emission tomography (PET) radiotracer is anticipated to witness robust expansion in the forthcoming years, with the valuation projected to reach $3.63 billion in 2029, reporting a compound annual growth rate (CAGR) of 9.1%. The upswing over the forecast period can be accredited to factors such as the broadening of applications, regulatory sanctions, rise in emerging markets, increase in the elderly population, and the escalating adoption of PET radio scanners. The key trends for the forecast period comprise the advent of micro-pet technology, synchronization with wearable technology, spreading of theranostics, nano-radiotracers, and the application of blockchain for information security.

Which Drivers Are Expected to Have the Greatest Impact on the Positron Emission Tomography (PET) Radiotracer Market’s Growth?

The surge in incidences of infectious diseases is predicted to spur the positron emission tomography (PET) radiotracer market’s expansion. Infectious diseases are ailments triggered by harmful microorganisms such as bacteria, viruses, parasites, and fungi. Factors like climate change, urbanization, global integration, resistance to antibiotics, and shifts in human behavior, which enable the transmission of pathogens, have led to the escalating prevalence of these diseases. PET radiotracers contribute to the management of infectious diseases by marking metabolic activity and inflammation, which eventually allows for the identification of infection, analysis of treatment effectiveness, and differentiating between infectious and non-infectious diseases, thus facilitating improved patient outcomes. For example, a report released by the UK Health Security Agency, a government organization in the UK, in February 2024 stated a 10.7% rise in tuberculosis (TB) cases in England in 2023, with 4,850 cases recorded, versus the 4,380 reported in 2022. Consequently, the growth of the positron emission tomography (PET) radiotracer market is being fueled by the escalating prevalence of infectious diseases.

Get Your Free Sample of the Global Positron Emission Tomography (PET) Radiotracer Market Report Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

Who Are the Key Market Players Influencing the Growth of the Positron Emission Tomography (PET) Radiotracer Industry?

Major companies operating in the positron emission tomography (PET) radiotracer marker are Cardinal Health Inc., AstraZeneca PLC, Eli Lilly and Company, Siemens Healthineers AG, GE Healthcare Technologies Inc., Philips Healthcare, Bracco Imaging S.p.A., Neusoft Medical Systems Co Ltd., Lantheus Holdings Inc., Jubilant Pharma Limited, SOFIE Biosciences (SOFIE), Yantai Dongcheng Pharmaceutical Group Co. Ltd., Nordion Inc., RefleXion Medical Inc., Isologic Innovative Radiopharmaceuticals, ABX Advanced Biochemical Compounds GmbH, IBA Radiopharma Solutions S.A., IXICO PLC, ImaginAb Inc., Radiomedix Inc.

What Key Market Trends Are Shaping the Future of the Positron Emission Tomography (PET) Radiotracer Industry?

Leading businesses in the PET radiotracer market are prioritizing the creation of innovative diagnostic tools such as PET imaging agents to boost the detection of cancer and improve patient prognosis. PET imaging agents are radioactive substances used in PET scans to view and track bodily functions. For example, in March 2023, IsoLogic Innovative Radiopharmaceuticals, a radiopharmaceutical firm based in Canada, introduced Illuccix, alternatively known as the Ga-68 Gozetotide Preparation Kit (PSMA-11) in Canada, which is a prostate cancer imaging agent specifically created to detect metastatic prostate cancer. This equipment is beneficial to doctors for detecting metastatic illnesses and assisting in patient care decisions. It is intended for use in patients suspected of developing metastasis and are considered for initial definitive treatment and those suspected of recurrence as signaled by a rise in serum prostate-specific antigen (PSA) levels.

Get Instant Access to the Global Positron Emission Tomography (PET) Radiotracer Market Report with Swift Delivery!

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which Primary Segments of the Positron Emission Tomography (PET) Radiotracer Market Are Driving Growth and Industry Transformations?

The positron emission tomography (PET) radiotracer market covered in this report is segmented –

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

Subsegments:

1) By F-18 (Fluorodeoxyglucose 18): F-18 FDG (Fluorodeoxyglucose), F-18 Fluoroethyltyrosine (FET), F-18 Florbetapir (Amyloid PET Imaging)

2) By Ga-68 (Fibroblast Activation Protein Inhibitor): Ga-68 Dotatate (Neuroendocrine Tumor Imaging), Ga-68 PSMA (Prostate-Specific Membrane Antigen Imaging), Ga-68 FAPI (Fibroblast Activation Protein Inhibitor Imaging)

3) By Other Radiotracer Types: C-11 (Carbon-11), N-13 (Nitrogen-13), O-15 (Oxygen-15), Rb-82 (Rubidium-82), I-124 (Iodine-124)

Which Regions Are Emerging as Leaders in the Positron Emission Tomography (PET) Radiotracer Market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Features of the Positron Emission Tomography (PET) Radiotracer Market?

A positron emission tomography (PET) radiotracer refers to a radioactive substance used in positron emission tomography (PET) imaging. A PET radiotracer is utilized by injecting a patient with a radioactive substance that binds to specific biological targets, allowing the PET scanner to visualize metabolic activity and diagnose conditions such as cancer or neurological disorders.

Browse Through More Similar Reports By The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Cloud-Radio Access Network Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-radio-access-network-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

What is the Expected Growth Rate of the Positron Emission Tomography (PET) Radiotracer Market from 2024 to 2033?

The PET radiotracer market is projected to grow from $2.15 billion in 2023 to $2.35 billion in 2024 at a CAGR of 9%, with growth fueled by infectious diseases, greater accessibility, novel radiotracers, cancer cases, and preventive medicine focus.

The positron emission tomography (PET) radiotracer market is projected to reach $3.33 billion by 2028, with a CAGR of 9.2%. This growth is attributed to expanded applications, regulatory approvals, emerging market growth, a growing geriatric population, and increased PET radio scanner adoption. Trends include the development of micro-PET technology, wearable tech integration, theranostics expansion, nano-radiotracers, and blockchain for data security.

Claim Your Free Sample of the Global Positron Emission Tomography (PET) Radiotracer Market Report Today!

https://www.thebusinessresearchcompany.com/sample.aspx?id=19152&type=smp

What Key Factors Are Fueling the Growth of the Positron Emission Tomography (PET) Radiotracer Market?

The growing prevalence of infectious diseases is expected to drive the positron emission tomography (PET) radiotracer market’s growth. Infectious diseases, caused by pathogens such as bacteria, viruses, fungi, or parasites, are becoming more common due to factors like climate change, urbanization, globalization, antibiotic resistance, and changes in human behavior. PET radiotracers are essential for detecting infections, assessing treatment responses, and distinguishing between infectious and non-infectious conditions. For example, a report from the UK Health Security Agency in February 2024 noted a 10.7% increase in tuberculosis (TB) cases in England in 2023. Therefore, the rising incidence of infectious diseases is fueling PET radiotracer market growth.

What Are the Major Segments of the Positron Emission Tomography (PET) Radiotracer Market?

1) By Radiotracer Type: F-18 (Fluorodeoxyglucose 18), Ga-68 (Fibroblast Activation Protein Inhibitor), Other Radiotracer Types

2) By Application: Cancer, Heart Disease, Gastrointestinal, Endocrine, Neurological Disorders, Other Applications

3) By End-User: Hospitals, Diagnostic Centers, Other End-Users

What New Trends Are Transforming the Positron Emission Tomography (PET) Radiotracer Market?

Companies in the positron emission tomography (PET) radiotracer market are focusing on advanced diagnostic solutions, such as PET imaging agents, to improve cancer detection and patient outcomes. A PET imaging agent is a radioactive substance used to visualize biological processes during PET scans. In March 2023, IsoLogic Innovative Radiopharmaceuticals launched Illuccix, a prostate cancer imaging agent in Canada, to detect metastatic prostate cancer. It aids physicians in identifying metastatic disease and making management decisions for patients with suspected recurrence based on elevated prostate-specific antigen levels.

Order Now for Fast Delivery of Your Positron Emission Tomography (PET) Radiotracer Market Report!

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-radiotracer-global-market-report

Which Regions Are Driving Growth in the Positron Emission Tomography (PET) Radiotracer Market?

North America was the largest region in the positron emission tomography (PET) radiotracer market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the positron emission tomography (PET) radiotracer marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Positron Emission Tomography (PET) Radiotracer Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the positron emission tomography (pet) radiotracer market, its market share, and analyzes key competitors along with their market positions.

The Table Of Content For The Positron Emission Tomography (PET) Radiotracer Market Include

1. Positron Emission Tomography (PET) Radiotracer Market Executive Summary

2. Positron Emission Tomography (PET) Radiotracer Market Segments

3. Positron Emission Tomography (PET) Radiotracer Market Size And Template Market Growth Rate

4. Key Positron Emission Tomography (PET) Radiotracer Market Trends

5. Major Positron Emission Tomography (PET) Radiotracer Market Drivers

……

25. Key Mergers And Acquisitions In The Positron Emission Tomography (PET) Radiotracer Market

26. Top Positron Emission Tomography (PET) Radiotracer Companies

27. Positron Emission Tomography (PET) Radiotracer Market Opportunities And Strategies

28. Positron Emission Tomography (PET) Radiotracer Market, Conclusions And Recommendations

29. Appendix

Discover Related Reports by The Business Research Company:

Positron Emission Tomography (PET) Scanners Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/positron-emission-tomography-pet-scanners-global-market-report

Single Photon Emission Computed Tomography (SPECT) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

Emission Monitoring System Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emission-monitoring-system-global-market-report

Learn More About The Business Research Company

The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: